dual amylin and calcitonin receptor agonists (Viking Therapeutics)

N/A

Report date: 2025/06/11 10:21:21
NME

Base Information

Drug Namedual amylin and calcitonin receptor agonists (Viking Therapeutics)
Drug Alias NameDACRA
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCalcitonin receptor agonistsAppetite suppressantAmylin receptor agonists
TargetsAmylin ReceptorCalcitonin receptor
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViking Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesViking Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A